Regeneron to ask FDA to expand EUA for antibody treatment after positive study results

A study found that an antibody combination made by Regeneron reduces the risk of death when given to patients with severe Covid who have not mounted a natural antibody response of their own. CNBC's Meg Tirrell reports.